TSX:LMAX Holdings Information

TSX:LMAX is an equity ETF with a total of 22 individual holdings. The top holdings are Amgen stock at 5.74%, AbbVie at 5.65%, Thermo Fisher Scientific at 5.65%, Vertex Pharmaceuticals at 5.61%, and Merck & Co. at 5.58%.

Total Holdings

Top 10 Percentage

54.70%

Asset Class

Equity

ETF Category

Health Care

Assets

232.37M

PE Ratio

22.30

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	AMGN	Amgen Inc.	5.74%	22,311
2	ABBV	AbbVie Inc.	5.65%	36,847
3	TMO	Thermo Fisher Scientific Inc.	5.65%	15,303
4	VRTX	Vertex Pharmaceuticals Incorporated	5.61%	17,225
5	MRK	Merck & Co., Inc.	5.58%	63,127
6	BMY	Bristol-Myers Squibb Company	5.46%	136,695
7	LLY	Eli Lilly and Company	5.30%	7,667
8	JNJ	Johnson & Johnson	5.29%	33,258
9	DHR	Danaher Corporation	5.25%	41,142
10	ABT	Abbott Laboratories	5.18%	78,445
11	UNH	UnitedHealth Group Incorporated	5.18%	22,231
12	CVS	CVS Health Corporation	5.16%	91,823
13	GILD	Gilead Sciences, Inc.	5.01%	57,269
14	PFE	Pfizer Inc.	4.98%	292,626
15	MDT	Medtronic plc	4.90%	90,389
16	CI	The Cigna Group	4.78%	28,937
17	MCK	McKesson Corporation	4.66%	8,795
18	SYK	Stryker Corporation	4.55%	23,485
19	BSX	Boston Scientific Corporation	3.83%	132,447
20	ISRG	Intuitive Surgical, Inc.	3.66%	16,258
21	n/a	Written Call Options	-0.57%	n/a
22	n/a	Cash And Other Assets/Liabilities	-0.83%	1,932,666

As of Aug 31, 2026